Section Arrow
Quote
MIST.NASDAQ
- Milestone Pharmaceuticals
Quotes are at least 15-min delayed:2026/04/15 15:35 EDT
Regular Hours
Last
 2.145
+0.115 (+5.67%)
Day High 
2.175 
Prev. Close
2.03 
1-M High
2.17 
Volume 
2.61M 
Bid
2.14
Ask
2.15
Day Low
1.9775 
Open
2 
1-M Low
1 
Market Cap 
238.86M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.69 
20-SMA 1.51 
50-SMA 1.65 
52-W High 3.06 
52-W Low 0.88 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.75/-0.64
Enterprise Value
296.59M
Balance Sheet
Book Value Per Share
0.36
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.55M
Operating Revenue Per Share
0.05
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
IMMPImmutep Limited0.6+0.2852+90.60%-- 
LIMNLiminatus Pharma Inc0.1923+0.0125+6.95%-- 
PPCBPropanc Biopharma Inc0.1117+0.0142+14.56%0PE
ALLOAllogene Therapeutics2.08-0.2-8.77%-- 
CUECue Biopharma0.6606+0.2226+50.82%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.